These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 2931729)

  • 1. Serotonin and vascular reactivity.
    Van Nueten JM; Janssens WJ; Vanhoutte PM
    Pharmacol Res Commun; 1985 Jul; 17(7):585-608. PubMed ID: 2931729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can peripheral serotonergic blockade explain the hypotensive effect of ketanserin?
    Vanhoutte PM
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S105-9. PubMed ID: 2412025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotonin and arterial vessels.
    Vanhoutte PM; Cohen RA; Van Nueten JM
    J Cardiovasc Pharmacol; 1984; 6 Suppl 2():S421-8. PubMed ID: 6206351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonin and the blood vessel wall.
    Van Nueten JM
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S49-51. PubMed ID: 2412058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenine nucleotides, serotonin, and endothelium-dependent relaxations to platelets.
    Houston DS; Shepherd JT; Vanhoutte PM
    Am J Physiol; 1985 Mar; 248(3 Pt 2):H389-95. PubMed ID: 3156512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotonin and the blood vessel wall.
    Vanhoutte PM; Lüscher TF
    J Hypertens Suppl; 1986 Apr; 4(1):S29-35. PubMed ID: 2939211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct and sensitizing effects of serotonin agonists and antagonists on vascular smooth muscle.
    Myers JH; Mecca TE; Webb RC
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S44-8. PubMed ID: 2412057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Augmentation of vasoconstrictor responses to serotonin by acute and chronic factors: inhibition by ketanserin.
    Van Nueten JM; Janssens WJ
    J Hypertens Suppl; 1986 Apr; 4(1):S55-9. PubMed ID: 2939213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotonin and the vascular system. Role in health and disease, and implications for therapy.
    Houston DS; Vanhoutte PM
    Drugs; 1986 Feb; 31(2):149-63. PubMed ID: 3512233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contractions of isolated canine coronary arteries resistant to S2-serotonergic blockade.
    Cohen RA
    J Pharmacol Exp Ther; 1986 May; 237(2):548-52. PubMed ID: 2939235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacology of potent and selective S2-serotonergic antagonists.
    Janssen PA
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S2-11. PubMed ID: 2412048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antagonism by methysergide of neurogenic vasoconstriction in the dog forelimb.
    Jandhyala BS; Kivlighn SD
    Fed Proc; 1987 Feb; 46(2):276-80. PubMed ID: 3100343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of serotonin, histamine, and thromboxane A2 in platelet-induced contractions of coronary arteries and aortae from rabbits.
    Awano K; Yokoyama M; Fukuzaki H
    J Cardiovasc Pharmacol; 1989 May; 13(5):781-92. PubMed ID: 2472528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-Hydroxytryptamine can mediate endothelium-dependent relaxation of coronary arteries.
    Cohen RA; Shepherd JT; Vanhoutte PM
    Am J Physiol; 1983 Dec; 245(6):H1077-80. PubMed ID: 6660308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction between S2-serotonergic and alpha 1-adrenergic receptor activities at vascular sites.
    Van Nueten JM; Janssens WJ; Xhonneux R; Janssen PA
    J Cardiovasc Pharmacol; 1988; 11 Suppl 1():S10-5. PubMed ID: 2459506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotonergic receptor subtypes and vascular reactivity.
    Van Nueten JM; Leysen JE; de Clerck F; Vanhoutte PM
    J Cardiovasc Pharmacol; 1984; 6 Suppl 4():S564-74. PubMed ID: 6210424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of U46619 on contractions to 5-HT, sumatriptan and methysergide in canine coronary artery and saphenous vein in vitro.
    Kemp BK; Cocks TM
    Br J Pharmacol; 1995 Oct; 116(4):2183-90. PubMed ID: 8564247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serotonin-S2 receptor binding sites and functional correlates.
    Leysen JE; de Chaffoy de Courcelles D; De Clerck F; Niemegeers CJ; Van Nueten JM
    Neuropharmacology; 1984 Dec; 23(12B):1493-501. PubMed ID: 6396526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotonin and the vascular wall.
    Vanhoutte PM
    Int J Cardiol; 1987 Feb; 14(2):189-203. PubMed ID: 3818135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition by ketanserin of serotonin induced cerebral arteriolar constriction.
    Thompson JA; Wei EP; Kontos HA
    Stroke; 1984; 15(6):1021-4. PubMed ID: 6506113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.